Announced
Completed
Synopsis
The Vistria Group, a private investment firm, completed the investment in Ora, an ophthalmic contract research organization. Financial terms were not disclosed. “Ora is a leader in ophthalmic clinical research, and we are delighted to partner with the Ora team in the next chapter of its growth. We invested in Ora because of its strong globally recognized brand, demonstrated innovation, service excellence, and tenured team of ophthalmology veterans, many who have worked together for decades, leading to an unparalleled record bringing over 85 drugs and devices to market. We are excited to build on Ora’s track record of success of partnering with customers and bringing new life-enhancing treatments to patients around the world,” Natasha Latif, The Vistria Group Partner for Healthcare.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.